Tainan, Taiwan

ChiaYing Lee

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Scinopharm Taiwan, Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: ChiaYing Lee. Retrieved from https://idiyas.com/inventor/chiaying-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: ChiaYing Lee: Innovator in Pharmaceutical Chemistry

Introduction

ChiaYing Lee is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds.

Latest Patents

ChiaYing Lee holds a patent for a "Method for preparing sugammadex sodium." This innovative process involves a specific formulation where X in formula II is a halo. His work in this area has the potential to enhance the efficacy of anesthetic practices.

Career Highlights

ChiaYing Lee is currently employed at Scinopharm Taiwan, Ltd., a company known for its advancements in pharmaceutical manufacturing. His role at Scinopharm has allowed him to focus on research and development, contributing to the company's reputation in the industry.

Collaborations

ChiaYing has collaborated with fellow researcher ShangHong Chen, furthering their collective efforts in pharmaceutical innovations.

Conclusion

ChiaYing Lee's contributions to the field of pharmaceutical chemistry, particularly through his patent on sugammadex sodium, highlight his role as an important innovator in the industry. His work continues to influence advancements in medical practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…